Development and validation of a short version of the Sarcopenia Quality of Life questionnaire: the SF-SarQoL

Autor:	Christian Monseur, Jean-Yves Reginster, Médéa Locquet, S. Gillain, Anton Geerinck, Olivier Bruyère, Charlotte Beaudart
Rok vydání:	2021
Předmět:	Quality of life Male Sarcopenia medicine.medical_specialty Psychometrics Delphi method 030209 endocrinology & metabolism Item response theory Article 03 medical and health sciences 0302 clinical medicine Surveys and Questionnaires Internal consistency Activities of Daily Living medicine Humans 030212 general & internal medicine Questionnaire development Reliability (statistics) Aged Public Health Environmental and Occupational Health Reproducibility of Results Construct validity Item reduction medicine.disease Physical therapy Female Psychology
Zdroj:	Quality of Life Research
ISSN:	1573-2649 0962-9343
DOI:	10.1007/s11136-021-02823-3
Popis:	Purpose To facilitate the measurement of quality of life in sarcopenia, we set out to reduce the number of items in the previously validated Sarcopenia Quality of Life (SarQoL®) questionnaire, and to evaluate the clinimetric properties of this new short form. Methods The item reduction process was carried out in two phases. First, information was gathered through item-impact scores from older people (n = 1950), a Delphi method with sarcopenia experts, and previously published clinimetric data. In the second phase, this information was presented to an expert panel that decided which of the items to include in the short form. The newly created SFSarQoL was then administered to older, community-dwelling participants who previously participated in the SarcoPhAge study. We examined discriminative power, internal consistency, construct validity, test–retest reliability, structural validity and examined item parameters with a graded response model (IRT). Results The questionnaire was reduced from 55 to 14 items, a 75% reduction. A total of 214 older, community-dwelling people were recruited for the validation study. The clinimetric evaluation showed that the SF-SarQoL® can discriminate on sarcopenia status [EWGSOP2 criteria; 34.52 (18.59–43.45) vs. 42.86 (26.56–63.69); p = 0.043], is internally consistent (α = 0.915, ω = 0.917) and reliable [ICC = 0.912 (0.847–0.942)]. A unidimensional model was fitted (CFI = 0.978; TLI = 0.975; RMSEA = 0.108, 90% CI 0.094–0.123; SRMR = 0.055) with no misfitting items and good response category separation. Conclusions A new, 14-item, short form version of the Sarcopenia Quality of Life questionnaire has been developed and shows good clinimetric properties.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6fe550e881d772510ddd49dc8c890b8 https://doi.org/10.1007/s11136-021-02823-3 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.